Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling
PaperCitations, authors & open-access status
The MEK Inhibitor Trametinib Ameliorates Kidney Fibrosis by Suppressing ERK1/2 and mTORC1 Signaling is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 76 citations, 2018 year and bronze oa status.
76
Citations
2018
Year
bronze
OA Status